Cigna to Acquire Express Scripts for $67 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Abbott plans to spin off its nutrition unit as a standalone public company
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- Anthropic logged net loss of over $80 billion in first half of 2026
William Blair Downgrades Express Scripts (ESRX) to Market Perform Amid Merger Announcement
March 8, 2018 12:51 PM ESTWilliam Blair downgraded Express Scripts (NASDAQ: ESRX) from Outperform to Market Perform following merger announcement.
For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.
Shares of Express Scripts closed at $73.42 yesterday.
... More


